Commonwealth Equity Services’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.43M Sell
16,600
-577
-3% -$156K 0.01% 1415
2025
Q4
$4.31M Sell
17,177
-660
-4% -$175K 0.01% 1429
2025
Q3
$5.12M Buy
17,837
+111
+0.6% +$29.7K 0.01% 1330
2025
Q2
$4.65M Sell
17,726
-4,050
-19% -$986K 0.01% 1374
2025
Q1
$5.07M Buy
21,776
+4,861
+29% +$1.18M 0.01% 1273
2024
Q4
$3.88M Sell
16,915
-1,783
-10% -$409K 0.01% 1403
2024
Q3
$4.18M Buy
18,698
+1,715
+10% +$377K 0.01% 1335
2024
Q2
$3.46M Sell
16,983
-551
-3% -$112K 0.01% 1425
2024
Q1
$3.83M Sell
17,534
-3,485
-17% -$768K 0.01% 1343
2023
Q4
$4.78M Buy
21,019
+366
+2% +$76.9K 0.01% 1126
2023
Q3
$4.15M Sell
20,653
-3,061
-13% -$646K 0.01% 1132
2023
Q2
$4.92M Buy
23,714
+843
+4% +$164K 0.01% 1045
2023
Q1
$4.51K Sell
22,871
-487
-2% -$100K 0.01% 1056
2022
Q4
$4.72M Buy
23,358
+107
+0.5% +$20.9K 0.01% 992
2022
Q3
$4.09M Buy
23,251
+5,061
+28% +$1.04M 0.01% 995
2022
Q2
$3.66M Buy
18,190
+1,452
+9% +$310K 0.01% 1065
2022
Q1
$3.79M Buy
16,738
+340
+2% +$80K 0.01% 1110
2021
Q4
$4.43M Buy
16,398
+57
+0.3% +$14.1K 0.01% 990
2021
Q3
$3.95M Sell
16,341
-159
-1% -$40.1K 0.01% 1012
2021
Q2
$3.91M Sell
16,500
-1,256
-7% -$286K 0.01% 991
2021
Q1
$3.89M Buy
17,756
+281
+2% +$56.4K 0.01% 908
2020
Q4
$3.06M Sell
17,475
-296
-2% -$51.1K 0.01% 983
2020
Q3
$2.87M Buy
17,771
+1,048
+6% +$166K 0.01% 911
2020
Q2
$2.39M Sell
16,723
-6,559
-28% -$907K 0.01% 942
2020
Q1
$2.53M Buy
23,282
+7,932
+52% +$1.14M 0.01% 786
2019
Q4
$2.23M Buy
15,350
+1,368
+10% +$198K 0.01% 967
2019
Q3
$2.02M Buy
13,982
+899
+7% +$131K 0.01% 970
2019
Q2
$1.94M Sell
13,083
-2,141
-14% -$299K 0.01% 977
2019
Q1
$2M Sell
15,224
-9,416
-38% -$1.16M 0.01% 922
2018
Q4
$2.67M Buy
24,640
+12,546
+104% +$1.68M 0.01% 708
2018
Q3
$1.8M Buy
12,094
+268
+2% +$40.8K 0.01% 977
2018
Q2
$1.82M Sell
11,826
-1,581
-12% -$239K 0.01% 945
2018
Q1
$1.86M Buy
13,407
+1,981
+17% +$291K 0.01% 903
2017
Q4
$1.57M Buy
11,426
+1,982
+21% +$262K 0.01% 974
2017
Q3
$1.23M Sell
9,444
-1,230
-12% -$164K 0.01% 1076
2017
Q2
$1.41M Sell
10,674
-147
-1% -$18K 0.01% 969
2017
Q1
$1.33M Buy
10,821
+1,787
+20% +$212K 0.01% 966
2016
Q4
$996K Sell
9,034
-2,392
-21% -$266K 0.01% 1034
2016
Q3
$1.35M Buy
11,426
+1,934
+20% +$228K 0.01% 858
2016
Q2
$1.06M Buy
9,492
+230
+2% +$24.8K 0.01% 945
2016
Q1
$932K Buy
9,262
+1,257
+16% +$121K 0.01% 984
2015
Q4
$850K Buy
8,005
+956
+14% +$98.6K 0.01% 1012
2015
Q3
$657K Buy
7,049
+609
+9% +$63K 0.01% 1107
2015
Q2
$671K Sell
6,440
-188
-3% -$19.6K 0.01% 1170
2015
Q1
$718K Buy
6,628
+1,449
+28% +$149K 0.01% 1131
2014
Q4
$480K Sell
5,179
-97
-2% -$8.57K 0.01% 1307
2014
Q3
$461K Sell
5,276
-61
-1% -$5.51K 0.01% 1295
2014
Q2
$470K Sell
5,337
-420
-7% -$36.4K 0.01% 1277
2014
Q1
$486K Buy
5,757
+155
+3% +$12.4K 0.01% 1179
2013
Q4
$440K Buy
5,602
+92
+2% +$7.85K 0.01% 1211
2013
Q3
$469K Buy
5,510
+278
+5% +$23.4K 0.01% 1120
2013
Q2
$450K Buy
+5,232
New +$434K 0.01% 1069

Other funds holding LH

Commonwealth Equity Services's LH Position: Q1 2026 in Review

Commonwealth Equity Services reduced its Labcorp (LH) stake by 3.4% in Q1 2026, selling an estimated $156K and leaving 16,600 shares worth $4.43M. The position accounts for 0.01% of the portfolio, ranked #1415.

Commonwealth Equity Services first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.12M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Commonwealth Equity Services held 16,600 shares of Labcorp worth $4.43M as of Q1 2026.
  • Commonwealth Equity Services sold 577 Labcorp shares in Q1 2026, an estimated $156K.
  • Labcorp made up 0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #1415 holding.
  • Commonwealth Equity Services first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Commonwealth Equity Services's Labcorp position peaked at $5.12M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.